UV LED Phototherapy
Systems
Technology
Applications
Research
News
Partnering
Management
Contact
Company Overview
Opthera, Inc. ("Opthera") is a biomedical company licensing exclusive rights to a patent for the use of ultra-violet light-emitting diodes ("UV LED") in tanning and phototherapy. The company is currently pursuing the development of several devices and is conducting research at several major research facilities across the country. Opthera's devices and research are targeting specific UVA wavelengths to treat Systemic Lupus Erythematosus ("SLE") and other autoimmune disorders.
Opthera's technology is developing the first major advancement Systemic Lupus Erythematosus therapy in over 40 years. Backed by 20 years of basic science and clinical research, Opthera is developing a commercialized version of a Lupus Phototherapy device that incorporates UV LED’s into a system that provides optimized UV light for the treatment of Systemic Lupus Erythematosus.
Latest News Release: November 6th, 2008, Albany, NY.
The Daily Gazette (Schenectady, NY ) has featured Christopher Macomber in an article titled "Aspiring doctor combines med school with business" . The article can be found in the newspaper's Health section and online (click here). The article describes Chris' ability to successfully combine interests in both medicine and business.
The article quotes Dr. Frank Rice, Ph.D., of the Center for Neuropharmacology and Nueroscience at Albany Medical College, "I think [t]his delivery system is very well thought out in taking the strategy of producing exactly the wave length[s] of light that one wants..."
For more information contact:
Christopher Macomber, COO
Opthera, Inc.
5 Upper Loudon Road
Loudonville, NY 12211
USA
email: ChrisMacomber@Opthera.com
###
All rights reserved